Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1992-08-10
1996-10-29
Parr, Margaret
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435 691, 435 711, 4351721, 4351723, 4353201, 536 235, 930 50, 935 22, 935 23, 935 52, 935 55, C12N 500, C12N 1500, C12P 2106, C07H 1700
Patent
active
055696015
ABSTRACT:
The present invention is directed toward the isolation, characterization and pharmacological use of the human D4 dopamine receptor. The nucleotide sequence of the gene corresponding to this receptor and alleleic variant thereof are provided by the invention. The invention also includes recombinant eukaryotic expression constructs capable of expressing the human D4 dopamine receptor in cultures of transformed eukaryotic cells. The invention provides cultures of transformed eukaryotic cells which synthesize the human D4 dopamine receptor, and methods for characterizing novel psychotropic compounds using such cultures.
REFERENCES:
Van Tol et al., Nature, vol. 350, 18 Apr. 1991, pp. 610-614.
Van Tol et al., Nature, vol. 358, 9 Jul. 1992, pp. 149-152.
Botstein et al., 1980, Am. J. Hum. Genet. 32:314-331.
Van Tol et al., 1991, Nauture 350:610-614.
Cooper et al., The Biochemical Basis of Neuropharmacology, 3d ed. 1978 (Oxford University Press: N.Y.), pp. 161-195.
Kababian and Calna, Nature 277:93-96 (1979).
Sanogles et al., Biochemistry 25:749-753 (1986).
Sangoles et al., J. Biol. Chem. 263:18996-19002 (1988).
Gingrich et al., J. Biochemistry 27:3907-3912 (1988).
Amlaiky et al., Mol. Pharmacol. 31:129-134 (1987).
Ninik et al., Biochemistry 27:7594-7599 (1988).
Amlaiky and Caron, J. Biol. Chem. 260:1983-1986 (1985).
Amlaiky and Caron, J. Neurohem. 47:196-204 (1986).
Jarvia et al., Mol. Pharmacol. 34:91-97 (1988).
Sokoloff et al., Nature 347:146-151 (1990).
Seaman et al., Neuropsychopharm. 1:5-15 (1987).
Seaman, Synapse 1:133-152 (1987).
Bunaew et al., Nature 336:783-787 (1988).
Grandy et al., Proc. Natl. Acad. Sci. U.S.A. 86:9762-9766 (1989).
Dal Toso et al., Embo. J. 8:4025-4034 (1989).
Zhou et al., Nature 348:76-80 (1990).
Sunahara et al., Nature 348:80-83 (1990).
Kane et al., Arch. Gan. Psychiat. 45:789-796 (1988).
Casey, Psychopharmacology 99:547-553 (1989).
Ackenheil et al., Arzneim-Forsch 26:1156-1158 (1976).
Bandoz Canada, Inc., Clozaril: Summary of preclinical and clinical data (1990).
Dohlman et al., Biochemistry 26:2657-2664 (1987).
Botstein et al., 1980, Am. J. Hum. Genet. 32:314-331.
Van Tol et al., 1991, Nature 350:610-614.
Van Tol et al., 1992, Nature 368:149-152.
Parr Margaret
Sisson Bradley L.
State of Oregon Acting by and Through the Oregon State Board of
LandOfFree
Human dopamine receptor and its uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human dopamine receptor and its uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human dopamine receptor and its uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785228